Page last updated: 2024-12-08

gulonolactone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

gulonolactone: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID165105
CHEBI ID177057
SCHEMBL ID1331510
MeSH IDM0051359

Synonyms (37)

Synonym
CHEBI:177057
(3r,4s,5s)-5-[(1r)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-one
d-(-)-gulonic acid gamma-lactone
6322-07-2
gulono-1,4-lactone
3327-64-8
C05410
gulonolactone
d-gulonic acid gamma-lactone, 97%
BAF290D4-5A2B-424C-9F26-37DBB214E76B
gulonic acid-1,4-lactone
d-(-)-gulono-gamma-lactone
SCHEMBL1331510
gulonic acid, gamma-lactone
einecs 228-678-5
d-gulono-1,4-lactone
nsc 34392
S3362
d-gulonic acid gamma-lactone
(3r,4s,5s)-5-((r)-1,2-dihydroxyethyl)-3,4-dihydroxydihydrofuran-2(3h)-one
mfcd00005391
d-gulono-gamma-lactone
(3r,4s,5s)-5-[(1r)-1,2-bis(oxidanyl)ethyl]-3,4-bis(oxidanyl)oxolan-2-one
(3r,4s,5s)-5-[(1r)-1,2-dihydroxyethyl]-3,4-dihydroxy-tetrahydrofuran-2-one
AKOS026751479
HY-118840
1,4-d-gulonolactone
DS-11667
d-gulonic acid |a-lactone
d-gulonic acid y-lactone
CS-0068648
A853223
i(3)-d-gluconolactone
EN300-317522
DTXSID001036177
d-gulonic acid ?-lactone
rel-(3r,4s,5s)-5-((r)-1,2-dihydroxyethyl)-3,4-dihydroxydihydrofuran-2(3h)-one

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Gulonolactone treatment of mice resulted in the elevation of hepatic ascorbate and hydrogen peroxide levels accompanied by transient liver swelling and reversible dilatation of endoplasmic reticulum cisternae. "( Intraluminal hydrogen peroxide induces a permeability change of the endoplasmic reticulum membrane.
Bánhegyi, G; Benedetti, A; Csala, M; Löw, P; Margittai, E; Szarka, A, 2008
)
1.79
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
gamma-lactoneA lactone having a five-membered lactone ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (35.29)18.7374
1990's7 (20.59)18.2507
2000's10 (29.41)29.6817
2010's3 (8.82)24.3611
2020's2 (5.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 48.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index48.28 (24.57)
Research Supply Index3.58 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index72.16 (26.88)
Search Engine Supply Index2.02 (0.95)

This Compound (48.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (5.71%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other33 (94.29%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]